RBC Bioscience Corporation (6848.TWO)
TWD 18.05
(0.28%)
TWD 18.05
(0.28%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 513.08 Million TWD | -5.29% |
| 2022 | 541.73 Million TWD | -8.3% |
| 2021 | 590.77 Million TWD | 74.84% |
| 2020 | 337.88 Million TWD | 1144.29% |
| 2019 | 27.15 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 523.57 Million TWD | 0.0% |
| 2024 Q1 | 523.57 Million TWD | 2.04% |
| 2023 Q2 | 526.6 Million TWD | 0.0% |
| 2023 Q4 | 513.08 Million TWD | 0.0% |
| 2023 FY | 513.08 Million TWD | -5.29% |
| 2023 Q1 | 526.6 Million TWD | -2.79% |
| 2023 Q3 | 513.08 Million TWD | -2.57% |
| 2022 Q3 | 541.73 Million TWD | 0.0% |
| 2022 FY | 541.73 Million TWD | -8.3% |
| 2022 Q4 | 541.73 Million TWD | 0.0% |
| 2021 FY | 590.77 Million TWD | 74.84% |
| 2020 FY | 337.88 Million TWD | 1144.29% |
| 2019 FY | 27.15 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 12.066% |
| Level Biotechnology Inc. | 273.2 Million TWD | -87.803% |
| Sagittarius Life Science Corp | 137.82 Million TWD | -272.273% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | -159.826% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 61.36% |
| GlycoNex Incorporation | 276.39 Million TWD | -85.631% |
| VBI | 21.25 Million TWD | -2314.385% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | -63.555% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 0.305% |
| Visgeneer Inc. | 185.6 Million TWD | -176.437% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 61.224% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 30.001% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -328.067% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 77.156% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -7652.811% |
| Enimmune corporation | 173.46 Million TWD | -195.787% |
| TaiRx, Inc. | 60.62 Million TWD | -746.319% |
| CHO Pharma, Inc. | 110.83 Million TWD | -362.936% |
| EirGenix Inc. | 1.14 Billion TWD | 55.193% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -358.186% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | -0.126% |
| Lin BioScience, Inc. | 167.73 Million TWD | -205.897% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -447.497% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -713.975% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | -311.357% |
| Lukas Biomedical Inc. | 161.05 Million TWD | -218.567% |
| BiOptic Inc. | 170.56 Million TWD | -200.816% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -1117.043% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -2106.326% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -1813.553% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 47.356% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -7236.017% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -2317.229% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | -39.299% |
| Neith Corporation | 17.43 Million TWD | -2843.16% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -6336.039% |
| NaviFUS Corp. | 53.4 Million TWD | -860.808% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | -6.562% |
| Sinew Pharma Inc. | 39.71 Million TWD | -1191.94% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -784.028% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | -40.772% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | -125.338% |
| AP Biosciences Inc | 106.65 Million TWD | -381.089% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 85.466% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -1572.309% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | -161.789% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 66.753% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 40.782% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -5431.274% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -819.286% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | -120.245% |
| TCI GENE Inc. | 155.54 Million TWD | -229.854% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -1911.451% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -1011.166% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | -56.203% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -690.73% |
| PharmaEngine, Inc. | 91 Million TWD | -463.788% |
| Savior Lifetec Corporation | 457.95 Million TWD | -12.037% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -362.485% |
| OBI Pharma, Inc. | 650.44 Million TWD | 21.119% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | -31.286% |
| Acepodia, Inc. | 384.47 Million TWD | -33.451% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -499.723% |